Latest news
Loading news…
Zentiva develops and manufactures generic medicines providing the NHS with low cost alternatives to branded medicines.
Zentiva was acquired by GTCR in 2025 for $5B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
5
Monthly Visits
Available in Pro Contacts
241
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Prague, Hlavni mesto Praha, Czech Republic
Acquisitions by Zentiva
Loading columns…
0 of 0Show
Page 1 / 1
241
professional contacts at Zentiva
Contact execs at Zentiva →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Zentiva
Loading news…
FAQs about Zentiva
People who checked this page also checked these
Sectors Zentiva invests & acquires in
Browse the full Acquirezy directory.